Prothena Corporation plc
PRTA
$9.17
-$0.04-0.43%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.68M | 11.79M | 10.34M | 137.94M | 135.16M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.68M | 11.79M | 10.34M | 137.94M | 135.16M |
| Cost of Revenue | 134.85M | 170.44M | 192.22M | 209.22M | 222.52M |
| Gross Profit | -125.17M | -158.65M | -181.88M | -71.28M | -87.36M |
| SG&A Expenses | 59.39M | 63.59M | 67.12M | 67.33M | 67.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 194.24M | 234.03M | 259.34M | 276.55M | 289.72M |
| Operating Income | -184.56M | -222.25M | -249.00M | -138.61M | -154.56M |
| Income Before Tax | -200.83M | -238.75M | -261.68M | -115.86M | -128.93M |
| Income Tax Expenses | 43.26M | 41.71M | 41.24M | -5.60M | -6.62M |
| Earnings from Continuing Operations | -244.09 | -280.46 | -302.92 | -110.27 | -122.31 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -244.09M | -280.46M | -302.92M | -110.27M | -122.31M |
| EBIT | -184.56M | -222.25M | -249.00M | -138.61M | -154.56M |
| EBITDA | -183.67M | -221.35M | -248.10M | -137.71M | -153.67M |
| EPS Basic | -4.53 | -5.21 | -5.63 | -2.05 | -2.27 |
| Normalized Basic EPS | -1.98 | -2.39 | -2.66 | -1.35 | -1.50 |
| EPS Diluted | -4.54 | -5.21 | -5.63 | -2.07 | -2.30 |
| Normalized Diluted EPS | -1.98 | -2.39 | -2.66 | -1.36 | -1.52 |
| Average Basic Shares Outstanding | 215.32M | 215.30M | 215.26M | 215.20M | 215.09M |
| Average Diluted Shares Outstanding | 215.32M | 215.30M | 215.26M | 216.48M | 216.36M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |